ADRO: Aduro Biotech, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 237.01
Enterprise Value ($M) 164.44
Book Value ($M) 34.53
Book Value / Share 0.82
Price / Book 6.86
NCAV ($M) -45.07
NCAV / Share -1.07
Price / NCAV -5.26

Profitability (mra)
Return on Invested Capital (ROIC) -1.26
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.61

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 11.27

Balance Sheet (mrq) ($M)
Current Assets 167.28
Assets 246.89
Liabilities 212.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -90.14
Net Income -82.37
Earnings Per Share Basic And Diluted -1.03
Earnings Per Share Diluted -1.03
Earnings Per Share Basic -1.03

Cash Flow Statement (mra) ($M)
Cash From Operations -65.51
Cash from Investing -1.76
Cash from Financing -1.76

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-08-03 10-Q Quarterly Report – 10-Q
2020-05-04 10-Q Quarterly Report – 10-Q
2020-03-09 10-K Annual Report – 10-K

(click for more detail)

Similar Companies
ABCL – AbCellera Biologics Inc. ABEO – Abeona Therapeutics Inc.
ABIO – ARCA biopharma, Inc. ABUS – Arbutus Biopharma Corporation
ACAD – ACADIA Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io